Biotech Public Relations: A Remedy for Low Awareness

Whether a top biotech firm like Amgen or Genentech or a start-up, all biotech companies need to employ a consistent biotech public relations strategy. Providing a steady and consistent flow of scientific news via biotech public relations is essential for the reputation and valuation of biotech companies.

Proactive biotech public relations should create news, not just get it reported. Whether placing news stories covering the launch of new research facilities, investor events, current testing and trials, newsworthy approvals, exciting mergers, vital fundraising, investment strategy stories, confidence-building staff announcements, strategic acquisitions or profit reports, or crisis management, generating consistent and positive exposure is essential for biotech public relations. Gaining investor confidence and appeal for venture capitalists, private equity and mergers and acquisitions through biotech public relations is the lifeblood for funding scientific breakthroughs and profitability.

Bring talented scientists to the forefront, branding them as experts in the biotech space and acting as biotech public relations brand ambassadors. In this regard, partner with a biotech PR firm whose biotech public relations strategies include make it a priority to generate exposure for their in-house assets. It creates additional avenues to highlight the brand, and associates expertise with company representatives in the process. These biotech public relations tactics can include placing op-ed articles, interviews, speaking engagements and guest contributions by experts with their views on current and future goals¬.

Because reputation and visibility are important factors when it comes to client acquisition, biotech public relations strategies should target broadcast, print and digital media outlets that reach corporate and individual audiences. Biotech public relations should also extend to networking for licensing and partnership opportunities. Social media is also a must, as more and more decision makers are digesting content in non-traditional areas. Making a large imprint via biotech public relations efforts digitally will also fuel search engine optimization.
For more information visit to http://www.makovsky.com